Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1672968 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CCAAT/enhancer Binding Protein (C/EBP), alpha (CEBPA) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human CEBPA, identical to the related mouse and rat sequence.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- -20°C
- Handling
- Avoid repeated freezing and thawing.
Submitted references The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.
Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene.
The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1.
Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S, Lister A, Rowley JD, Huegli B, Fey MF, Pabst T
Proceedings of the National Academy of Sciences of the United States of America 2004 Sep 7;101(36):13312-7
Proceedings of the National Academy of Sciences of the United States of America 2004 Sep 7;101(36):13312-7
Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene.
Swart GW, van Groningen JJ, van Ruissen F, Bergers M, Schalkwijk J
Biological chemistry 1997 May;378(5):373-9
Biological chemistry 1997 May;378(5):373-9
The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1.
Hendricks-Taylor LR, Bachinski LL, Siciliano MJ, Fertitta A, Trask B, de Jong PJ, Ledbetter DH, Darlington GJ
Genomics 1992 Sep;14(1):12-7
Genomics 1992 Sep;14(1):12-7
No comments: Submit comment
No validations: Submit validation data